Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. EHA S826: Eltrombopag Added to Standard Immunosuppression as First Treatment in Severe Aplastic Anemia

    ... counts and decreases bleeding risk. This phase 2 clinical trial tested the efficacy of adding eltrombopag to immunosuppressive ...

    Research Review last updated 05/02/2016 - 9:10am.

  2. Safety Study of Cord Blood Units for Stem Cell Transplants

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... BLOOD who are participating in an NIH-IRB approved clinical trial for unrelated hematopoietic stem cell transplantation. ...

    Clinical Trial last updated 05/09/2016 - 3:25pm.

  3. Amer Zeidan, M.D.

    ... Smith at Johns Hopkins University where he has completed a clinical hematology/oncology fellowship and a clinical research ... Zeidan and his colleagues designed and initiated an ongoing trial that uses an antibody to stimulate the immune system in patients with MDS ...

    Bio last updated 03/11/2016 - 1:41pm.

  4. Clinical Trials Report for March 2015

    ... We have highlighted some clinical trials currently recruiting patients. Each has a specific purpose ... anemia , MDS, or PNH. Should you consider a clinical trial ?  Ask your doctor or contact the study coordinators for further ...

    Page last updated 03/02/2015 - 10:06am.

  5. Phase 1 Study of TCP-ATRA for Adult Patients With AML and MDS (TCP-ATRA)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... that ATRA combined with TCP will be safe and effective in a clinical population, and that this approach will suppress LICs and restore ...

    Clinical Trial last updated 04/29/2016 - 12:33pm.

  6. Shyamala Navada, MD

    ... She is currently completing a Masters of Science in Clinical Research in the graduate school at Mount Sinai.  Her primary ... She will be the principal investigator of a clinical trial combining azacitidine and rigosertib in MDS patients that ...

    Bio last updated 03/11/2016 - 1:41pm.

  7. Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... The purpose of this Phase I, multicenter, clinical trial is to evaluate the safety of AG-120 and AG-221 when given in ...

    Clinical Trial last updated 04/28/2016 - 4:16pm.

  8. CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Purpose:  This pilot clinical trial studies 6, 8-bis (benzylthio) octanoic acid (CPI-613) in ...

    Clinical Trial last updated 04/28/2016 - 2:09pm.

  9. Human Placental-Derived Stem Cell Transplantation (HPDSC)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Purpose:  The purpose of this clinical trial is to investigate the safety of human placental-derived ...

    Clinical Trial last updated 04/26/2016 - 3:15pm.

  10. Safety and Efficacy of Oral Azacitidine (CC-486) Administered in Extended Treatment Schedules to Patients with Lower-Risk Myelodysplastic Syndromes

    ... oral version of azacitidine in a multicenter, phase 1 clinical trial . This trial is enrolling patients with lower-risk MDS who need ...

    Research Review last updated 05/02/2016 - 9:27am.